ArticleFrontiers in cardiovascular medicine2026
Pantoprazole-induced anaphylactic asthma and Type I Kounis syndrome: a case report and literature review.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Proton pump inhibitors (PPIs) are among the most frequently prescribed medications and are generally considered to have a favourable safety profile. Nevertheless, immediate hypersensitivity reactions may occur and, in exceptional circumstances, can precipitate Kounis syndrome (KS), an acute coronary syndrome resulting from the activation of inflammatory pathways. We describe an elderly patient who developed severe anaphylaxis with Type I KS shortly after intravenous pantoprazole administration in the presence of an unsuspected myocardial bridge, and discuss the potential clinical implications. Case summary: An 85-year-old woman with a 30-year history of well-controlled bronchial asthma was admitted with community-acquired pneumonia. During hospitalization, she received intravenous pantoprazole (40 mg) for acid reflux. Within five minutes of the infusion, she developed a widespread erythematous rash, severe bronchospasm, profound hypotension (74/56 mmHg), and ST-segment elevation of approximately 0.3 mV in leads I, aVL, and V₁ to V₄. Emergency coronary angiography demonstrated no obstructive coronary artery disease but identified a myocardial bridge involving the mid-left anterior descending artery, producing nearly 90% systolic compression. Serial cardiac troponin and NT-proBNP concentrations remained within the normal range. Assessment using the Naranjo Adverse Drug Reaction Probability Scale yielded a score of six, indicating a probable causal relationship between pantoprazole and the adverse event. The patient was treated with methylprednisolone (80 mg). The recovery occurred within 2 h. Conclusion: This case highlights that intravenous pantoprazole may rarely trigger life-threatening Type I Kounis syndrome. It also raises the possibility that a pre-existing myocardial bridge can accentuate coronary vasospasm during severe allergic reactions, thereby contributing to the clinical presentation. Based on this experience and the available literature, we propose a practical management algorithm to facilitate timely diagnosis and treatment in similar clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.